<DOC>
	<DOCNO>NCT00726960</DOCNO>
	<brief_summary>The objective study determine whether aprepitant block opiate reward system non-dependent opiate abuser , indicate potential safe , non-addictive first line therapy early heroin abuse .</brief_summary>
	<brief_title>Ability Aprepitant Block Opioid Reward Non-Dependent Opiate Abusers</brief_title>
	<detailed_description>This initial proof-of-concept study focus evaluate whether NK1 antagonist , aprepitant , block opiate reward non-dependent opiate experience volunteer response standard opiate challenge . Sixty subject include randomize control study . Following training challenge session , receive 1 week treatment aprepitant matching placebo , follow challenge session subjective physiological response opiate partial agonist buprenorphine assess .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Opioid-Related Disorders</mesh_term>
	<mesh_term>Substance-Related Disorders</mesh_term>
	<mesh_term>Heroin Dependence</mesh_term>
	<mesh_term>Aprepitant</mesh_term>
	<mesh_term>Fosaprepitant</mesh_term>
	<mesh_term>Buprenorphine</mesh_term>
	<criteria>Age 18 50 Current opiate use , without dependence Clinical diagnosis opiate dependence Positive urine screen opiate day challenge session Meet diagnostic criterion substance abuse disorder except nicotine within last 12 month . Any ongoing prescription medication oral contraceptive hormone replacement Any serious medical condition judgment investigator make administration opiate medically inappropriate .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>July 2008</verification_date>
	<keyword>Heroin abuse</keyword>
	<keyword>Opioids</keyword>
	<keyword>Opiates</keyword>
	<keyword>Substance abuse</keyword>
	<keyword>Addiction</keyword>
</DOC>